As of Mar 29
| +0.07 / +0.08%|
The 15 analysts offering 12-month price forecasts for Charles River Laboratories International Inc have a median target of 95.00, with a high estimate of 106.00 and a low estimate of 67.00. The median estimate represents a +6.23% increase from the last price of 89.43.
The current consensus among 20 polled investment analysts is to Buy stock in Charles River Laboratories International Inc. This rating has held steady since March, when it was unchanged from a Move your mouse over past
months for detail
Move your mouse over a quarter or year to see how estimates have changed over time.